comparemela.com

Latest Breaking News On - ஆண்டனி டௌப்மந் - Page 3 : comparemela.com

Bolivia notifies to the WTO its need to import Covid-19 vaccines using TRIPS flexibilities

Bolivia notifies to the WTO its need to import Covid-19 vaccines using TRIPS flexibilities May 13, 2021 TRIPS Agreement was amended through the 2005 protocol   -  Dado Ruvic× The country can look at the possibility of imports from 50 members including India Bolivia has formally notified to the WTO its need to import Covid-19 vaccines as part of its pandemic response that may be allowed using flexibilities in WTO intellectual property rules This opens up the possibility of importing the needed vaccines from any one of around 50 countries, including India, that have put in place necessary domestic laws providing for the production and export of medicines made under compulsory licence, said an official release of the WTO on Thursday.

Bolivia importará vacunas bajo flexibilización de normas comerciales

Bolivia importará vacunas bajo flexibilización de normas comerciales
prensa-latina.cu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prensa-latina.cu Daily Mail and Mail on Sunday newspapers.

Bolivia busca 15 millones de dosis tras liberar patentes

Bolivia busca 15 millones de dosis tras liberar patentes
opinion.com.bo - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from opinion.com.bo Daily Mail and Mail on Sunday newspapers.

Bolivia signs deal to import J&J vaccine from Canadian company, pending patent issues

Bolivia signs deal to import J&J vaccine from Canadian company, pending patent issues Jacquelyn LeBel © supplied by Biolyse Pharma Biolyse Pharma in St. Catharines, Ont., is hoping to obtain a compulsory licence. A Canadian company hoping to contribute to the world’s vaccination efforts says it has reached a deal to provide 15 million doses of the single-dose Johnson & Johnson/Janssen COVID-19 vaccine to Bolivia, but it cannot move ahead until it is allowed to actually produce it. Biolyse Pharma, an Ontario-based manufacturer, says it already has the capacity to produce up to 20 million doses annually of an already-approved viral-vector COVID-19 vaccine, like the AstraZeneca or Johnson & Johnson vaccines, with the potential to produce 50 million doses.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.